State Rep. Peter Barca
Press Release

Statement from Rep. Barca on Senate passage of amended oral chemo bill

Today the Senate passed an amended version of the oral chemotherapy bill, which the Assembly passed last month.

By - Apr 1st, 2014 03:48 pm

MADISON – Today the Senate passed an amended version of the oral chemotherapy bill, which the Assembly passed last month. In response, Assembly Democratic Leader Peter Barca (D-Kenosha) released the following statement:

“After working cooperatively five years ago with advocates, cancer survivors and other supporters to author the original bill, I am proud that the legislature has passed oral chemo legislation that will allow cancer patients all across our state to have better and more affordable access to life-saving treatment.

“Wisconsin is now that much closer to joining Minnesota, Iowa, Illinois and many other states in enacting oral chemo legislation to ensure individuals fighting cancer get the essential, life-saving care they need.

“While I believe the bill could have been even stronger, it will still provide tremendous help for the thousands of brave Wisconsinites fighting this deadly disease. I look forward to Gov. Walker signing this important legislation into law.”

Mentioned in This Press Release

Recent Press Releases by State Rep. Peter Barca

Connecting Workers with Career Opportunities

RTA Builds Transportation Options in Southeastern Wisconsin

Statement from Rep. Barca on Republican Budget

"Republicans should be ashamed of this budget."

State Rep. Peter Barca

Statement from Rep. Barca on the Assembly Passage of Foxconn Bill

"Along with my Democratic colleagues, I’ll work tirelessly to make this a better deal."

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us